Clinical Trial Update: Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer [NA]

View source ↗

Summary

A terminated clinical trial evaluated splenectomy-omitting radical pancreatectomy in well-selected left-sided pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Yonsei University | Conditions: Left-sided Pancreatic Cancer, Ductal Adenocarcinoma | NA | Status: TERMINATED